BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17351391)

  • 1. Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data.
    Bracht K; Liebeke M; Ritter CA; Grünert R; Bednarski PJ
    Anticancer Drugs; 2007 Apr; 18(4):389-404. PubMed ID: 17351391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.
    Bracht K; Kiefer T; Dölken G; Bednarski PJ
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):957-67. PubMed ID: 17562080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data.
    Bracht K; Boubakari ; Grünert R; Bednarski PJ
    Anticancer Drugs; 2006 Jan; 17(1):41-51. PubMed ID: 16317289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
    Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collateral sensitivity: ABCG2-overexpressing cells are more vulnerable to oxidative stress.
    Krzyżanowski D; Bartosz G; Grzelak A
    Free Radic Biol Med; 2014 Nov; 76():47-52. PubMed ID: 25064323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas.
    Mickisch G; Bier H; Bergler W; Bak M; Tschada R; Alken P
    Urol Int; 1990; 45(3):170-6. PubMed ID: 1971972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
    Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
    Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
    Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
    Campling BG; Baer K; Baker HM; Lam YM; Cole SP
    Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
    Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
    Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP; Downes HF; Mirski SE; Clements DJ
    Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
    Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
    Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
    Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
    Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
    Lee FY; Sciandra J; Siemann DW
    Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity.
    Coley HM; Labeed FH; Thomas H; Hughes MP
    Biochim Biophys Acta; 2007 Apr; 1770(4):601-8. PubMed ID: 17270349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A; Daly AK; Atherton K; Campbell FC
    Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells.
    Paul S; Breuninger LM; Kruh GD
    Biochemistry; 1996 Nov; 35(44):14003-11. PubMed ID: 8909298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
    Vaidya SS; Walsh SW; Gerk PM
    Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.